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Abstract 
In multiple sclerosis (MS), there is increasing evidence that demyelination, 
and neuronal damage within and beyond lesions, occurs preferentially in 
cortical grey matter (GM) next to the outer surface of the brain. It has been 
suggested that this may be due to the effects of pathology outside the brain 
parenchyma, in particular meningeal inflammation or through cerebrospinal 
fluid (CSF) mediated factors. White matter (WM) lesions are often located 
adjacent to the ventricles of the brain, suggesting the possibility of a similar 
outside-in pathogenesis, but an investigation of the relationship of 
periventricular normal-appearing (NA) WM abnormalities with distance from 
the ventricles has not previously been undertaken. The present study 
investigates this relationship in vivo using quantitative MR imaging and 
compares the abnormalities between SPMS and relapsing remitting (RR) MS. 
Forty-three people with RRMS and 28 with SPMS, and 38 healthy controls, 
were included in this study. T1-weighted volumetric, magnetisation transfer 
(MT) and PD/T2-weighted scans were acquired for all subjects. From the MT 
data, MT ratio (MTR) maps were prepared. WM tissue masks were derived 
from SPM8 segmentations of the T1-weighted images. NAWM masks were 
generated by subtracting WM lesions identified on the PD/T2 scan, and a 2 
voxel perilesional ring, from the SPM8 derived WM masks. WM was divided in 
concentric bands, each about 1 mm thick, radiating from the ventricles toward 
the cortex. The first periventricular band was excluded from analysis to 
mitigate partial volume effects, and NAWM and lesion MTR values were then 
computed for the ten bands nearest to the ventricles. Compared with controls, 
MTR in the NAWM bands was significantly lower in MS. In controls, MTR was 
highest in the band adjacent to the ventricles and declined with increasing 
distance from the ventricles. In the MS groups, relative to controls, reductions 
in MTR were greater in the SPMS compared with RRMS group, and these 
reductions were greatest next to the ventricles and became smaller with 
distance from them. WM lesion MTR reductions were also more apparent 
adjacent to the ventricle and decreased with distance from the ventricles in 
both the RR and SPMS groups. These findings suggest that in people with 
MS, and more so in SPMS than RRMS, tissue structural abnormalities in 
NAWM and WM lesions are greatest near the ventricles. This would be 
consistent with a CSF or ependymal mediated pathogenesis. 
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 Introduction 
 
The pathogenesis of progressive multiple sclerosis (MS) remains unknown, 
but recent studies have raised the possibility of factors external to the brain 
parenchyma playing a significant role. In people with secondary progressive 
(SP) MS, grey matter (GM) lesions may be as or more extensive than white 
matter (WM) lesions (Lassmann, 2013; Bo et al., 2003), and GM lesions are 
much more abundant in the outer (subpial) cortical layers when compared 
with the cortex next to WM (Bo et al., 2003). Similarly, neuronal loss in MS 
may be substantial in the cortex (Wegner et al., 2006), and is also greatest in 
the outer (subpial) compared with inner cortical layers (Magliozzi et al., 2010). 
This gradient in cortical GM lesions and neuronal pathology has been linked 
with meningeal inflammation, in particular the presence of B-cell follicle-like 
aggregates in secondary progressive (SP) MS (Magliozzi et al., 2010; 
Magliozzi et al., 2007), and it has been suggested that meningeal 
inflammation or CSF-mediated factors may play a key pathogenic role in 
cortical pathology. 
 
WM lesions occur more frequently around the ventricle than elsewhere, and a 
clear explanation for this distribution has not been found (Narayanan et al., 
1997). They appear to form around veins, and in the case of periventricular 
lesions around subependymal veins (Adams et al., 1987), but the mechanism 
for this has not been determined. Perivascular (venous) inflammatory 
infiltrates are seen in MS lesions (Adams, 1975), but it is not known if they are 
necessary for lesion genesis or part of a more chronic process. Tissue 
hypoxia has been suggested as having a pathogenic role in lesion formation 
(Lassmann, 2003), and for haemodynamic reasons periventricular WM may 
be more likely than other parts of the brain to become hypoxic, explaining the 
predilection for lesion formation in this region (Beggs, 2013). Patchy “granular 
ependymitis” has also been observed in a single study by Adams et al. 
(Adams et al., 1987), although only co-localised with about 1 in 10 
periventricular lesions. 
 
In light of findings in cortical GM, which suggest a possible outside-in 
pathogenesis, it would be of interest to know if the characteristics of normal-
appearing (NA) WM were also dependent on their location relative to the 
ventricular CSF interface. However, there is a paucity of histopathological or 
magnetic resonance imaging (MRI) studies that have looked for such an 
association in periventricular NAWM. One histopathological study looked at 
WM lesion features dependent on their distance from the ventricles, 
specifically looking at glial progenitor cell density, and found that it was 
highest in the lesions in the sub ventricular (sub ependymal) zone (Nait-
Ousmesmar et al. 2007). One MRI study looked at WM lesion features 
dependent on their distance from the ventricles, which found that lesions are 
more likely to be hypo-intense on T1-weighted images the closer they are to 
the ventricles (Papadopoulou et al., 2014). 
 
Magnetisation transfer ratio (MTR) is a magnetic resonance imaging (MRI) 
technique that has proven sensitive to MS pathology in WM lesions and 
NAWM (Horsfield, 2005). In combined MRI and histopathological studies, 
reductions in MTR have been found to correlate with both demyelination and 
axonal loss, and as such it is sensitive to two major elements of WM 
pathology in MS (Schmierer et al., 2004). With recent technical advances, it is 
now possible to obtain MTR maps at 1mm isotropic resolutions, and this has 
allowed us to subdivide the cortex into inner and outer bands. We found a 
preferential MS disease effect on the outer (subpial) relative to the inner 
cortex in people with SPMS (Samson et al., 2014). 
 
In this work, using the same high resolution MTR method, we aimed to 
investigate two questions:  
 
1. In people with RRMS and SPMS, is there a relationship between NAWM 
and WM lesion MTR, and distance from the ventricles? 
2. Are periventricular NAWM and lesion MTR abnormalities more prominent in 
SPMS compared with RRMS? 
 
Materials and Methods 
 
Subjects 
 
Participants were between 18 and 65 years old. Those with MS had to have a 
diagnosis of clinically definitive MS according to McDonald criteria (Polman et 
al. 2005), and MS subtypes were classified using the Lublin-Reingold (Lublin 
et al. 1996) criteria. The control group had to have no known neurological 
disease. All participants provided written informed consent. This study was 
approved by our local institutional ethics committee. 
 
We included 71 people with MS: 43 with RRMS and 28 with SPMS. The mean  
± standard deviation (SD) ages were 42.5 ± 10.0and 53.0 ± 8.1 respectively, 
and disease duration from first symptom onset was 11.7 ± 8.1and 21.9 ± 10.4. 
Forty-eight (68%) were female. The median EDSS (Kurtzke, 1983) was 5.5 
(range 1-8.5). Thirty-five (49%) of the MS group were receiving a disease-
modifying treatment at time of the study. Thirty-eight people served as 
controls, mean (SD) age 39.1 ± 11.9, 21 (55%) females. 
 
Magnetic resonance imaging 
 
Using a 3T Philips Achieva system (Philips Healthcare, Best, The 
Netherlands) with a 32-channel head coil and multi-transmit technology, the 
following sequences were acquired: 3D sagittal T1-weighted fast field echo 
(FFE) scan: 1x1x1 mm3, inversion time (TI)=824 ms, repetition time (TR)=6.9 
ms, echo time (TE)=3.1 ms; dual-echo proton density/T2-weighted axial-
oblique scans aligned with the anterior to posterior commissure line (1x1x3 
mm3, TR=3500 ms, TE=19/85 ms); and high resolution MT imaging using a 
3D slab-selective FFE sequence with two echoes (1x1x1 mm3, TR=6.4 ms, 
TE=2.7/4.3 ms, alpha=9° with and without sinc-Gaussian shaped MT pulses 
of nominal alpha=360°, offset frequency 1kHz, duration 16ms. A turbo field 
echo (TFE) readout was used, with an echo train length of four, TFE shot 
interval 32.5 ms, giving a total time between successive MT pulses of 50ms, 
and scan time ~25 minutes). The two echoes were averaged (thereby 
increasing the SNR) for both the MT on and MT off data used to calculate the 
MTR. 
 
Image analysis 
 
Segmentation of T1-w 3D images 
 
The T1-weighted scans were segmented using Statistical Parametric Mapping 
(SPM8; Wellcome Trust Centre for Neuroimaging, London, UK 
[www.fil.ion.ucl.ac.uk/]; using the new segment pipeline) after WM lesion filling 
(Chard et al. 2010), and the resultant GM, WM and CSF probability maps 
were then binarised. To minimise the potential for partial volume effects 
between tissues, the probability of each voxel being of a given tissue type had 
to be ≥90% (Samson et al., 2014). In addition, brain parenchymal fraction 
(BPF; GM and WM tissue volume divided by GM, WM plus CSF volume) was 
measured using the same SPM8 tissue segmentations, for use as a covariate 
in the statistical models. 
 
Extraction of normal appearing white matter 
 
WM lesions were identified and contoured on PD/T2 scans using JIM (Version 
6.0, Xinapse Systems, Northants). For each participant the WM lesion masks 
from the PD/T2 images were then co-registered to the corresponding T1-w 3D 
scan. To achieve this a pseudo-T1 image was generated by subtracting the 
PD from the T2-weighted image (Hickman et al., 2002), so providing an image 
with a similar contrast to the T1-w 3D scan. Using NiftyReg (Modat et al., 
2010; Ourselin et al., 2001), a linear transformation was then computed to co-
register the pseudo-T1 image to the T1-w 3D image, and then the same 
transformation was applied to the PD/T2 lesion mask. A previous study has 
shown that MTR is significantly more abnormal in the WM 1-2mm adjacent to 
the edge of an MS lesion, as seen on a PD/T2-weighted scan, when 
compared with WM more distant from the lesion margin (Vrenken et al., 
2006). To prevent this from affecting normal appearing (NA) WM MTR 
measurements in this study, a perilesional tissue mask was prepared by 
dilating the PD/T2 lesion mask 2 mm in each direction. Binarised WM lesions 
and perilesional tissue masks were then subtracted from each subject’s 
binarised WM mask to create a NAWM mask. As further precaution against 
lesion contamination of NAWM, the same analysis was rerun using a 3 voxels 
dilation of WM lesion masks. The results of this analysis are reported in the 
Supplementary Materials. 
 
 
Coregistration of MT data to T1-w images 
 
MTon and MToff images for each subject were affine registered to T1-w volume 
image using NiftyReg, and MTR maps calculated (MTR = (MToff - MTon) / 
MToff), measured in percentage units (pu). 
 
Segmentation of WM into concentric periventricular 1 voxel thick bands 
 
For each subject NAWM was segmented into concentric 1 voxel-thick bands 
starting at the ventricular margin and extending in to the brain parenchyma 
(Figure 1). To prevent NAWM bands arising simultaneously from the body and 
temporal horns of the lateral ventricles from clashing, only WM and ventricular 
CSF superior to the insula were included in the analysis (Figure 1). 
 
For each subject, a mask of the body of the lateral ventricles was first created 
by linearly co-registering their thresholded CSF map with the lateral ventricle 
mask included in the Wake Forest University School of Medicine PickAtlas 
toolbox (Maldjian et al., 2003). This mask was reviewed and if required 
manually edited (by ZL) to ensure a robust match with lateral ventricle 
anatomy in each subject. The CSF mask was then repeatedly dilated by 1 
voxel (1 x 1 x 1mm3) using DilM (part of the FSL software package 
(http://www.fmrib.ox.ac.uk/fsl/) through NAWM to generate concentric 1 voxel-
thick NAWM bands. In each subject, sequential bands were extracted until the 
volume of any given band fell below 0.5 ml. This yielded a series of NAWM 
bands extending from the ventricles through to the cortex. As an extra 
precaution against periventricular CSF-WM partial volume effects, data from 
the first band was not included in subsequent analyses. As the aim of this 
study was to look for periventricular MS disease effects, MTR values were 
extracted for the first 10 NAWM bands (i.e. covering ~1cm of distance 
between the ventricles and cortex). 
 
WM lesion measures 
 
To calculate WM lesion volumes and MTR values dependent on their distance 
from the ventricles, a similar procedure to that used to obtain NAWM data was 
used. Ventricular CSF was sequentially dilated by 1 voxel (as above) through 
the WM lesion mask, so generating a set of concentric WM lesion masks. 
Mean and SD WM lesion MTR and volumes were then calculated.  
 
Statistical analyses 
 
Demographic data and MTR values are presented as mean ± SD. EDSS 
values are presented as median (range). Statistical analyses were computed 
using SPSS (version 22, IBM). In each subject, MTR values within each 
NAWM band were averaged. The average MTR in each NAWM band was 
then separately compared between groups using general linear models, 
including age and gender as potentially confounding factors. Rather than run 
different models for each possible pairwise combination of groups, all three 
study groups (HC, RRMS and SPMS) were included in a single model for 
each NAWM band, so allowing group differences to be tested simultaneously. 
As a further precaution against CSF partial volume effects, and to allow for 
potential differences in the relative alignment of NAWM bands due to disease 
associated atrophy, both the total number of NAWM bands extracted and BPF 
were included as additional covariates. Gradients in NAWM MTR were 
calculated between pairs of bands and divided by the number of intervals 
spanned (e.g. the MTR gradient between bands 1 and 5 was calculated by 
subtracting the mean MTR value in band 5 from that in band 1, and dividing 
by 4). P≤0.05 was considered to be the threshold for statistical significance.  
 
Results 
 
Participant demographics, clinical characteristics, and MTR values are given 
in Table 1. Figure 2 shows the mean (standard error) NAWM MTR in each 
group. Figure 3a shows the corresponding WM lesion MTR values and Figure 
3b the WM lesion volumes.  
 
From Figure 2 it can be seen that in healthy controls, the NAWM MTR was 
highest in the immediate periventricular NAWM band, and then declined with 
distance from the ventricles. In people with MS, NAWM MTR was lower than 
that in controls (Table 2). The MS-associated reduction in MTR was greatest 
in the NAWM adjacent to the ventricles, and noticeably declined with 
increasing distance from the ventricles until band 5. Whereas in controls MTR 
was higher in band 1 than band 5, in MS MTR was higher in band 5 than band 
1. We therefore tested between group differences in NAWM MTR in bands 1, 
5 and (for reference) 10, and MTR gradients between bands 1 and 5, and 5 
and 10. 
 
Compared with controls MTR was significantly lower in bands 1, 5 and 10 in 
overall MS groups, as well as in RRMS and SPMS subgroups (Table 2). In 
band 1 MTR was significantly lower in the SPMS compared with RRMS group 
(Table 2). Age effects were not significant. Gender had a significant effect in 
band 5 and 10, however this did not materially alter the observed inter-group 
differences and so unadjusted results are presented (Table 2). Covarying for 
BPF or for the number of bands extracted did not materially alter the results, 
except for the comparison of MTR in band 1 between RRMS and SPMS 
groups, which reduced the statistical significance of differences between them 
to a borderline level (see supplemental Table 1). Compared with controls, 
MTR gradients between bands 1 and 5 differed significantly with both the MS 
subgroups or overall MS groups (Table 3). Between bands 5 and 10, changes 
in MTR differed significantly between the control and the MS groups (Table 3). 
Comparing the MS subgroups, NAWM MTR gradients between bands 1 and 5 
were significantly greater in the SPMS compared with RRMS group. Age and 
gender were not significant in these models, and covarying for the total 
number of bands or BPF did not materially affect them (see supplemental 
Table 2), and so unadjusted results are presented. 
 
Lesion MTR and volume by distance from the ventricles is shown in Figure 3 
and 4. It can be seen that with distance from the ventricles lesion volume 
decreases, and from bands 1 to 5 lesion MTR increases. Beyond band 5, 
lesions volumes are very small, and lesion MTR measures becomes more 
variable, but as with NAWM, they appear to plateau and then decline, so 
mirroring (at a lower level) the MTR gradient between bands seen in control 
WM. Dilating the WM lesion masks by 3 voxels did not materially alter the 
(see Supplemental Table 3-4 and Supplemental Figure 1).  
 
 
Discussion 
 
In the MS groups MTR was reduced throughout the NAWM, however the 
distribution of MTR values did not simply mirror, at a lower level, those in 
healthy controls. Instead, there was a clearly greater MS disease effect close 
to the ventricles. Similar findings were noted in WM lesions, with the 
magnitude of MTR reductions within lesion decreasing with distance from the 
ventricles. These findings strongly indicate that not only are lesions more 
likely to occur around the ventricles (Narayanan et al., 1997) (Figure 3b), but 
pathological changes within NAWM and WM lesions are also greater around 
the ventricles (Figure 2 and 3a). This suggests that pathology in WM occurs 
preferentially at or near the inner surface of the brain. 
 
Considering technical factors that may have influenced these results, 
inclusion of ventricular CSF in the NAWM and WM lesions masks could 
spuriously reduce periventricular MTR. However, we think this is highly 
unlikely for four reasons. First, we used a stringent threshold (90%) to binarise 
the SPM8 tissue segmentations. Second, we discarded MTR data in the first 
NAWM and WM lesion bands in each subject. Third, covarying for the total 
number of NAWM bands or BPF (a measure of brain atrophy) in the statistical 
analyses did not materially alter the results. Fourth, there was no 
periventicular reduction in MTR seen in controls, and we would expect to see 
at least a hint of this if partial volume with CSF was significantly affecting 
periventricular NAWM MTR measures.  
 
It is also highly unlikely that there was any lesion contamination of NAWM 
(which would reduce NAWM MTR). First, based on work by Vrenken et al. 
(Vrenken et al., 2006), who demonstrated that perilesional reductions in MTR 
were detectable for 1 to 2 mm, we dilated our lesion masks by 2 voxels i.e. 
the linear equivalent of at least 2 mm, making it very unlikely that any residual 
lesions or perilesional tissues could have contributed significantly to NAWM 
measures. We also re-ran the analysis dilating lesions by 3 voxels, and this 
did not materially alter the results (see Supplementary Materials). Secondly, 
the pattern of changes between bands in NAWM MTR (Figure 2) and WM 
lesion MTR (Figure 3a) are similar, and this would be difficult to account for 
through consistent partial volume between them. Further investigation of 
whether or not periventricular NAWM MTR abnormalities occur independently 
of lesions could be undertaken by studying subjects who do not have 
periventricular lesions. We could not investigate this in our cohort as almost 
all had periventricular lesions, which is usually the case in established MS. A 
future study of people with clinically isolated syndromes or clinically very early 
MS – more of whom may not have periventricular lesions – would be of 
interest. 
 
Brain atrophy could lead to the relative position of NAWM bands differing 
between people, e.g. band 10 in one person may fall a quarter of the way 
from the ventricular margin to the cortex, while in another person it may be 
halfway between them. However, misalignment of NAWM bands due atrophy 
could not account for the MTR gradients seen (as it will tend to flatten 
gradients within each group) or differences between groups (as it will increase 
variability in group-wide MTR measures within each band). However, as a 
further precaution we also included both the total number of NAWM bands 
extracted and BPF as covariates in the statistical models, and this did not 
materially alter the results. 
 
A gradient in disease-associated MTR reductions was seen in all MS groups, 
but the periventricular reduction was significantly greater in the SPMS group 
when compared with RRMS. Several possible mechanisms might contribute 
to preferential periventricular abnormalities in MS, although with the currently 
limited information available it is not possible to determine which is the 
primary one. First, CSF mediated factors may be relevant. This could provide 
a unifying explanation for the predilection for cortical GM pathology to occur 
next to the outer surface of the brain (Bo et al., 2003; Magliozzi et al., 2007; 
Magliozzi et al., 2010; Samson et al., 2014) and the periventricular NAWM 
MTR gradients seen in the present study. CSF from people with MS has been 
shown to induce both oligodendrocyte (Hughes and Field, 1967) and neuronal 
damage in cell cultures (Vidaurre et al., 2014). Secondly, inflammatory activity 
in the ependyma may be a factor. In a single histopathological study, Adams 
et al. (1987) found the ependyma overlying periventricular WM to be focally 
abnormal, and interpreted this as representing ependymitis. Thirdly, it has 
been suggested that periventricular WM is more likely than other WM regions 
to become hypoxic when oxygen availability is reduced (Beggs, 2013), 
although hypoxia is also only thought to be a significant factor in the 
pathogenesis of a minority of WM lesions (Lucchinetti et al., 2000; Lassmann, 
2003). 
  
The differences in the observed MTR gradients between people with MS and 
healthy controls are very difficult to explain on the basis of technical factors, 
such as partial volume, alone. However, there are some other limitations to 
consider. Because of the morphological complexity of dilating the whole 
ventricular system through WM, and the potential for bands arising from the 
body of lateral ventricles overlapping with those from the temporal horns, we 
restricted our analysis to tissues above the insula. In addition, specific 
pathological interpretation of WM MTR is difficult as it is sensitive to both 
demyelination and axonal loss (Schmierer et al., 2004), demyelination and 
axonal loss are highly correlated (Schmierer et al., 2004), and so we cannot 
determine which is mostly responsible for the gradient seen. In a recent spinal 
cord study in people with MS, a reduction in MTR has also been observed in 
the outermost cord voxel layer and, in addition to demyelination and axonal 
loss, the possibility of a direct effect of inflammatory infiltrates was also raised 
(Kearney et al., 2014). Quantitative histopathological assessment of the 
ependyma and periventricular WM is warranted to provide further insight into 
the cause of the MTR abnormalities observed in this study. 
 
In conclusion, we have found a gradient in MTR abnormalities from 
periventricular through to deep NAWM in people with MS, with the most 
marked abnormality seen in the immediate periventricular region and in 
SPMS. In combination with previous observations about cortical pathology, 
this suggests that there is a predilection for pathology to occur near the 
surface of the brain, particularly in SPMS. The present results highlight the 
need for further work clarifying the potential role of factors such as CSF 
mediators, ependymal inflammation, and periventricular tissue hypoxia, in the 
pathogenesis of lesional and non-lesional abnormalities in MS, and of SPMS. 
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Tables 
 
Table1 Participant characteristics 
 
 HC RRMS SPMS 
Number 38 43 28 
Mean age, years ± SD 
(range) 
39.1 ± 11.9 
(23-63) 
42.5 ± 10.0 (25-
64) 
53.0 ± 8.1 (36-
65) 
Gender M/F 17/21 14/29 9/19 
Median EDSS (range) NA 2 (1.0-7.0) 6.5 (4.0-8.5) 
Disease Duration, 
years ± SD 
NA 11.7 ± 8.1 21.9 ± 10.4 
Mean MTR in whole 
NAWM ± SD 
39.7 ± 0.8 38.9 ± 1.5 38.4 ±1.9 
Mean number of bands 
extracted ± SD 
44.0 ± 3.2 42.7 ± 3.2 41.1 ± 3.8 
Mean BPF ± SD 0.82 ± 0.02 0.80 ± 0.02 0.80 ± 0.03 
 
 
 
EDSS = Expanded Disability Status Scale; HC = health controls; NA = not 
available; NAWM = normal appearing white matter; MTR = magnetisation 
transfer ratio;  RRMS = relapsing-remitting multiple sclerosis; SD = standard 
deviation; SPMS = secondary progressive multiple sclerosis; BPF = brain 
parenchymal fraction. 
 Table 2  Mean MTR values in NAWM bands 1, 5 and 10 from lateral ventricle 
 
Band Type Mean (SE) MTR (pu) Differences 
1 
HC 41.0 (0.14)  HC vs RRMS: p<0.001 
HC vs SPMS: p<0.001 
RRMS vs SPMS: p=0. 019 All MS 38.9 (0.19) 
RRMS 39.2 (0.24) 
SPMS 38.4 (0.27) 
5 
HC 40.6 (0.13) HC vs RRMS: p<0.001 
HC vs SPMS: p<0.001 
RRMS vs SPMS: p=0.152 All MS 39.2 (0.15) 
RRMS 39.4 (0.20) 
SPMS 39.0 (0.22) 
10 
HC 40.3 (0.14) HC vs RRMS: p<0.001 
HC vs SPMS: p<0.001 
RRMS vs SPMS: p=0.258 All MS 39.1 (0.14) 
RRMS 39.3 (0.18) 
SPMS 39.0 (0.21) 
 
 
 
HC = health controls; MS = multiple sclerosis; MTR = magnetisation transfer 
ratio; pu = percent units; RRMS = relapsing-remitting multiple sclerosis; SE = 
standard error; SPMS = secondary progressive multiple sclerosis.  
 
  
Table 3  MTR gradients between NAWM bands 1, 5 and 10 
 
Bands Type Mean (SE) MTR 
change (pu, per band 
interval) 
Differences 
1 to 5 HC -0.11 (0.01) HC vs RRMS: p<0.001 
HC vs SPMS: p<0.001 
RRMS vs SPMS: p=0.027 All MS 0.08 (0.03) 
RRMS 0.04 (0.03) 
SPMS 0.14 (0.04) 
5 to 10 HC -0.07 (0.01) HC vs RRMS: p=0.007 
HC vs SPMS: p=0.001 
RRMS vs SPMS: p=0.253 All MS -0.02 (0.01) 
RRMS -0.03 (0.01) 
SPMS -0.01 (0.02) 
 
 
HC = health controls; MTR = magnetisation transfer ratio; pu = percent units; 
RRMS = relapsing-remitting multiple sclerosis; SE = standard error; SPMS = 
secondary progressive multiple sclerosis.  
 Figures 
 
Figure 1. NAWM above the superior limit of the insula was segmented into 
concentric periventricular 1 voxel thick bands. 
 
 
 
 
 
 
Figure 2. NAWM band MTR in each subgroup, mean ± 2 x standard error. 
MTR is given in percent units (pu). 
 
 
 
 
 
 
 
Figure 3a. WM lesion band MTR for each band in the RRMS and SPMS 
groups, mean ± 2 x standard error. 
 
 
 
 
 
 
 
Figure 3b. WM lesion band volume for each band in the RRMS and SPMS 
groups, mean ± 2 x standard error. 
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